Bassot A, Dragic H, Haddad S, Moindrot L, Odouard S, Corlazzoli F
Cell Death Dis. 2023; 14(9):630.
PMID: 37749143
PMC: 10519979.
DOI: 10.1038/s41419-023-06117-z.
Todosenko N, Khlusov I, Yurova K, Khaziakhmatova O, Litvinova L
Int J Mol Sci. 2023; 24(10).
PMID: 37240338
PMC: 10219319.
DOI: 10.3390/ijms24108993.
Teo A, Lim V, Yang V
Cancers (Basel). 2023; 15(3).
PMID: 36765536
PMC: 9913386.
DOI: 10.3390/cancers15030577.
Moukengue B, Lallier M, Marchandet L, Baudhuin M, Verrecchia F, Ory B
Cancers (Basel). 2022; 14(14).
PMID: 35884563
PMC: 9322921.
DOI: 10.3390/cancers14143503.
Huang Z, Xu Y, Wan M, Zeng X, Wu J
Int J Biol Sci. 2021; 17(1):236-246.
PMID: 33390846
PMC: 7757049.
DOI: 10.7150/ijbs.51123.
MicroRNA-340-5p inhibits colon cancer cell migration via targeting of RhoA.
Algaber A, Al-Haidari A, Madhi R, Rahman M, Syk I, Thorlacius H
Sci Rep. 2020; 10(1):16934.
PMID: 33037251
PMC: 7547089.
DOI: 10.1038/s41598-020-73792-9.
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma.
Otoukesh B, Abbasi M, Gorgani H, Farahini H, Moghtadaei M, Boddouhi B
Cancer Cell Int. 2020; 20:254.
PMID: 32565738
PMC: 7302353.
DOI: 10.1186/s12935-020-01342-4.
Lentinan up-regulates microRNA-340 to promote apoptosis and autophagy of human osteosarcoma cells.
Xu H, Dai J, Hu T, Liao Y
Int J Clin Exp Pathol. 2020; 11(8):3876-3883.
PMID: 31949775
PMC: 6962797.
LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340.
Yu J, Ou Z, Lei Y, Chen L, Su Q, Zhang K
Hum Cell. 2019; 33(1):148-158.
PMID: 31776854
DOI: 10.1007/s13577-019-00303-y.
MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.
Ren Z, He M, Shen T, Wang K, Meng Q, Chen X
Cancer Biol Ther. 2019; 21(3):231-240.
PMID: 31718519
PMC: 7012158.
DOI: 10.1080/15384047.2019.1683331.
Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines.
Zhu X, Tian G, Quan J, He P, Liu J
Int J Mol Med. 2019; 44(2):643-651.
PMID: 31173161
PMC: 6605470.
DOI: 10.3892/ijmm.2019.4213.
MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer.
Maimaitiming A, Wusiman A, Aimudula A, Kuerban X, Su P
Oncol Res. 2019; 28(1):13-19.
PMID: 30982494
PMC: 7851537.
DOI: 10.3727/096504019X15519249902838.
miRNA signatures in childhood sarcomas and their clinical implications.
Viera G, Salomao K, de Sousa G, Baroni M, Delsin L, Pezuk J
Clin Transl Oncol. 2019; 21(12):1583-1623.
PMID: 30949930
DOI: 10.1007/s12094-019-02104-z.
EPEL promotes the migration and invasion of osteosarcoma cells by upregulating ROCK1.
Chen S, Liu Z, Lu S, Hu B
Oncol Lett. 2019; 17(3):3133-3140.
PMID: 30867743
PMC: 6396117.
DOI: 10.3892/ol.2019.9975.
Rho Kinase Type 1 (ROCK1) Promotes Lipopolysaccharide-induced Inflammation in Corneal Epithelial Cells by Activating Toll-Like Receptor 4 (TLR4)-Mediated Signaling.
Gong J, Guan L, Tian P, Li C, Zhang Y
Med Sci Monit. 2018; 24:3514-3523.
PMID: 29804125
PMC: 5999052.
DOI: 10.12659/MSM.907277.
Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan B, Wu L, Pan L, Yang Y, Li H, Dai Y
Biosci Rep. 2018; 38(4).
PMID: 29769415
PMC: 6117618.
DOI: 10.1042/BSR20171615.
MicroRNA-216b reduces growth, migration and invasion of pancreatic ductal adenocarcinoma cells by directly targeting ρ-associated coiled-coil containing protein kinase 1.
Liu Y, Zhang Y, Zheng Z, Li K, Wu X, Du Q
Oncol Lett. 2018; 15(5):6745-6751.
PMID: 29616134
PMC: 5876443.
DOI: 10.3892/ol.2018.8109.
miFAST: A novel and rapid microRNA target capture method.
Poenitzsch Strong A, Berry S, Beebe D, Li J, Spiegelman V
Mol Carcinog. 2018; 57(4):559-566.
PMID: 29350431
PMC: 8858646.
DOI: 10.1002/mc.22780.
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.
Unterbruner K, Matthes F, Schilling J, Nalavade R, Weber S, Winter J
PLoS One. 2018; 13(1):e0190437.
PMID: 29293623
PMC: 5749791.
DOI: 10.1371/journal.pone.0190437.
SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.
Huang T, Zhou Y, Zhang J, Wong C, Li W, Kwan J
Oncogene. 2017; 37(9):1159-1174.
PMID: 29234151
PMC: 5861093.
DOI: 10.1038/s41388-017-0029-7.